Metastatic Neuroendocrine Prostate Cancer clinical trials

Explore recruiting metastatic neuroendocrine prostate cancer clinical trials.

Recruiting metastatic neuroendocrine prostate cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metastatic Neuroendocrine Prostate Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase I, open-label, multi-center exploratory safety and efficacy study with PSMA, SSTR2 and GRPR targeted radioligand therapy in metastatic neuroendocrine prostate cancer

France, Germany, Italy, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Metastatic Neuroendocrine Prostate Cancer trials by city

Metastatic Neuroendocrine Prostate Cancer in Toronto Metastatic Neuroendocrine Prostate Cancer in Vancouver Metastatic Neuroendocrine Prostate Cancer in Montreal Metastatic Neuroendocrine Prostate Cancer in Calgary Metastatic Neuroendocrine Prostate Cancer in Edmonton Metastatic Neuroendocrine Prostate Cancer in Ottawa Metastatic Neuroendocrine Prostate Cancer in Winnipeg Metastatic Neuroendocrine Prostate Cancer in Quebec City Metastatic Neuroendocrine Prostate Cancer in Hamilton Metastatic Neuroendocrine Prostate Cancer in Kitchener Metastatic Neuroendocrine Prostate Cancer in London Metastatic Neuroendocrine Prostate Cancer in Halifax Metastatic Neuroendocrine Prostate Cancer in New York Metastatic Neuroendocrine Prostate Cancer in Los Angeles Metastatic Neuroendocrine Prostate Cancer in Chicago Metastatic Neuroendocrine Prostate Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease